Search results
Factor II, Human
Imidazole buffer pH 7.30
Buffer for clotting assays (plasma samples). Diluent for plasma
vWF Deficient Plasma, lyophilised
For any in vitro analysis that requires human vWF deficient plasma.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.
HEMOCLOT LA-C (Confirm)
Reagent with low phospholipid concentration for confirming the presence of lupus anticoagulants (LA). The presence of LA does not or only insignificantly prolong clotting time.
HEMOCLOT LA-S (Screen)
Reagent with low phospholipid concentration for lupus anticoagulants (LA) determination. The presence of LA prolongs clotting time.
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
CEPHEN APTT LS 1 (Lupus Sensitive)
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
HEMOCLOT DTI 2.5 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.